ENTRY       D12277                      Drug
NAME        Ilofotase alfa (USAN/INN)
FORMULA     C4634H7226N1300O1429S36
EXACT_MASS  105102.2674
MOL_WEIGHT  105167.1508
SEQUENCE    VIPAEEENPA FWNRQAAEAL DAAKKLQPIQ KVAKNLILFL GDGLGVPTVT ATRILKGQKN
            GKLGPETPLA MDRFPYLALS KTYNVDRQVP DSAATATAYL CGVKANFQTI GLSAAARFNQ
            CNTTRGNEVI SVMNRAKQAG KSVGVVTTTR VQHASPAGTY AHTVNRNWYS DADMPASARQ
            EGCQDIATQL ISNMDIDVIL GGGRKYMFPM GTPDPEYPAD ASQNGIRLDG KNLVQEWLAK
            HQGAWYVWNR TELMQASLDQ SVTHLMGLFE PGDTKYEILR DPTLDPSLME MTEAALRLLS
            RNPRGFYLFV EGGRIDHGHH EGVAYQAVTE AVMFDDAIER AGQLTSEEDT LTLVTADHSH
            VFSFGGYPLR GSSIFGLAPG KARDRKAYTV LLYGNGPGYV LKDGARPDVT ESESGSPEYR
            QQSAVPLDEE THGGEDVAVF ARGPQAHLVH GVQEQSFVAH VMAFAACLEP YTACDLALPA
            CTTD
            (Disulfide bridge: 121-183, 467-484, 481-481', 121'-183', 467'-484')
  TYPE      Peptide
EFFICACY    Enzyme replacement (intestinal alkaline phosphatase)
  TYPE      Enzyme replacement therapy product
COMMENT     Treatment of sepsis-associated acute kidney injury
TARGET      ALPI (IAP) [HSA:248] [KO:K01077]
  PATHWAY   hsa00730(248)  Thiamine metabolism
            hsa00790(248)  Folate biosynthesis
BRITE       Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Phosphatases
                ALPI (IAP)
                 D12277  Ilofotase alfa (USAN/INN)
DBLINKS     CAS: 2387636-92-0
///
